###begin article-title 0
Processing of Genome 5' Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction
###end article-title 0
###begin p 1
Conceived and designed the experiments: FW VW US MH AM IA JK AM AP. Performed the experiments: VW EM MH PZ IA JK AM MS. Analyzed the data: FW EM US MH AM PZ IA JK AM MS AP. Contributed reagents/materials/analysis tools: EM US AM IA JK AM MS. Wrote the paper: FW AP.
###end p 1
###begin p 2
###xml 594 605 <span type="species:ncbi:205488">Ebola virus</span>
###xml 607 618 <span type="species:ncbi:121791">Nipah virus</span>
###xml 620 631 <span type="species:ncbi:11620">Lassa virus</span>
###xml 637 660 <span type="species:ncbi:11588">Rift Valley fever virus</span>
###xml 917 930 <span type="species:ncbi:11599">Hantaan virus</span>
###xml 932 969 <span type="species:ncbi:11593">Crimean-Congo hemorrhagic fever virus</span>
###xml 974 993 <span type="species:ncbi:12455">Borna disease virus</span>
###xml 1265 1278 <span type="species:ncbi:11599">Hantaan virus</span>
###xml 1280 1317 <span type="species:ncbi:11593">Crimean-Congo hemorrhagic fever virus</span>
###xml 1322 1341 <span type="species:ncbi:12455">Borna disease virus</span>
Innate immunity is critically dependent on the rapid production of interferon in response to intruding viruses. The intracellular pathogen recognition receptors RIG-I and MDA5 are essential for interferon induction by viral RNAs containing 5' triphosphates or double-stranded structures, respectively. Viruses with a negative-stranded RNA genome are an important group of pathogens causing emerging and re-emerging diseases. We investigated the ability of genomic RNAs from substantial representatives of this virus group to induce interferon via RIG-I or MDA5. RNAs isolated from particles of Ebola virus, Nipah virus, Lassa virus, and Rift Valley fever virus strongly activated the interferon-beta promoter. Knockdown experiments demonstrated that interferon induction depended on RIG-I, but not MDA5, and phosphatase treatment revealed a requirement for the RNA 5' triphosphate group. In contrast, genomic RNAs of Hantaan virus, Crimean-Congo hemorrhagic fever virus and Borna disease virus did not trigger interferon induction. Sensitivity of these RNAs to a 5' monophosphate-specific exonuclease indicates that the RIG-I-activating 5' triphosphate group was removed post-transcriptionally by a viral function. Consequently, RIG-I is unable to bind the RNAs of Hantaan virus, Crimean-Congo hemorrhagic fever virus and Borna disease virus. These results establish RIG-I as a major intracellular recognition receptor for the genome of most negative-strand RNA viruses and define the cleavage of triphosphates at the RNA 5' end as a strategy of viruses to evade the innate immune response.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 365 368 358 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Bowie1">[1]</xref>
###xml 370 373 363 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Pichlmair1">[2]</xref>
###xml 502 505 488 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Iwasaki1">[3]</xref>
###xml 591 594 570 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-GarciaSastre1">[4]</xref>
###xml 596 599 575 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Haller1">[5]</xref>
The efficacy of the innate immune response against virus infections is highly dependent on a rapid production of interferons and other cytokines. To achieve this, all nucleated cells are endowed with a cytoplasmic signaling cascade leading from the detection of intruded virus particles to the expression of cytokines, including type-I interferons (IFN-alpha/beta) [1], [2]. IFN-alpha/beta directly induce an antiviral state that alleviates the virus burden but also initiate adaptive immune responses [3]. Viruses that block expression of IFN-alpha/beta are therefore often highly virulent [4], [5].
###end p 4
###begin p 5
###xml 179 195 179 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Orthomyxoviridae</italic>
###xml 211 222 211 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Filoviridae</italic>
###xml 239 252 239 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rhabdoviridae</italic>
###xml 268 283 268 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paramyxoviridae</italic>
###xml 299 311 299 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arenaviridae</italic>
###xml 341 353 341 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bunyaviridae</italic>
###xml 448 455 448 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002032-t001">Table 1</xref>
###xml 639 642 639 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Eaton1">[6]</xref>
###xml 643 646 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Geisbert1">[9]</xref>
###xml 198 209 <span type="species:ncbi:205488">Ebola virus</span>
###xml 225 237 <span type="species:ncbi:11292">rabies virus</span>
###xml 255 266 <span type="species:ncbi:121791">Nipah virus</span>
###xml 286 297 <span type="species:ncbi:11620">Lassa virus</span>
###xml 366 389 <span type="species:ncbi:11588">Rift Valley fever virus</span>
###xml 391 404 <span type="species:ncbi:11599">Hantaan virus</span>
###xml 409 446 <span type="species:ncbi:11593">Crimean-Congo hemorrhagic fever virus</span>
An important group of pathogens causing emerging and re-emerging diseases are viruses with a negative-stranded RNA genome (NSVs). Prominent examples are influenza viruses (family Orthomyxoviridae), Ebola virus (Filoviridae), rabies virus (Rhabdoviridae), Nipah virus (Paramyxoviridae), Lassa virus (Arenaviridae), and several members of the Bunyaviridae family e.g. Rift Valley fever virus, Hantaan virus, or Crimean-Congo hemorrhagic fever virus (Table 1). These pathogens can cause rapid, systemic and often fatal illnesses which are characterized either by a fulminant pneumonia and multi-organ failure or by a severe hemorrhagic fever [6]-[9].
###end p 5
###begin title 6
Negative-strand RNA viruses (NSVs).
###end title 6
###begin p 7
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Hiscott1">[10]</xref>
NSV particles consist of a lipid envelope and a genome which is encapsidated by the viral nucleocapsid protein and polymerase. The genome is present either as one continuous strand of RNA (nonsegmented NSVs), or is divided into two, three, or up to eight segments. Upon infection of a host cell, the NSV genome first needs to be transcribed into mRNAs in order to furnish the proteins necessary for virus replication. In the course of these events, the incoming nucleocapsids must be unwrapped and the genomic RNA exposed. Cells, in turn, are able to sense the infection and activate an innate immune response. They immediately synthesize cytokines, most prominently the antivirally active type I interferons, but also other pro-inflammatory cytokines and chemokines [10].
###end p 7
###begin p 8
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Andrejeva1">[11]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Yoneyama1">[13]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Weber1">[14]</xref>
###xml 615 619 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Hornung1">[15]</xref>
###xml 621 625 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Pichlmair2">[16]</xref>
###xml 766 770 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Hornung1">[15]</xref>
###xml 772 776 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Pichlmair2">[16]</xref>
###xml 722 734 <span type="species:ncbi:11292">rabies virus</span>
###xml 739 765 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
The main intracellular sensors to recognize viral RNA structures and trigger cytokine synthesis are the RNA helicases RIG-I and MDA5 [11]-[13]. Until very recently, it was assumed that the only viral agonist of these pathogen recognition receptors (PRRs) is double-stranded RNA (dsRNA) which is generated as a by-product of genome replication. However, we have recently found that NSVs are exceptional in not producing substantial amounts of dsRNA [14]. Instead, the genomic single-stranded RNA (ssRNA) bearing a 5' triphosphate group was shown to be sufficient to activate RIG-I dependent IFN-alpha/beta induction [15], [16]. The importance of RIG-I for recognizing genomic RNA has been demonstrated for influenza virus, rabies virus and vesicular stomatitis virus [15], [16], but for none of the other NSVs.
###end p 8
###begin p 9
Here, we tested genomic RNA isolated from highly pathogenic NSVs to investigate whether activation of RIG-I is a common denominator. Our results not only establish RIG-I as the main intracellular sensor for the genome of both nonsegmented and segmented NSVs, but also show that some viruses are able to escape RIG-I-dependent cytokine induction by a hitherto unrecognized stealth strategy.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Genomic RNAs from highly virulent nonsegmented NSVs activate the IFN system
###end title 11
###begin p 12
###xml 63 74 63 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Filoviridae</italic>
###xml 105 120 105 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paramyxoviridae</italic>
###xml 297 310 297 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g001">Fig. 1A and B</xref>
###xml 492 499 489 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g001">Fig. 1C</xref>
###xml 821 828 815 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g001">Fig. 1D</xref>
###xml 30 47 <span type="species:ncbi:186538">Zaire Ebola virus</span>
###xml 80 91 <span type="species:ncbi:121791">Nipah virus</span>
###xml 198 215 <span type="species:ncbi:11320">influenza A virus</span>
###xml 329 334 <span type="species:ncbi:9606">human</span>
###xml 528 532 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
We tested the genomic RNAs of Zaire Ebola virus (ZEBOV, family Filoviridae) and Nipah virus (NiV, family Paramyxoviridae) for the capability to activate an innate immune response. RNA isolated from influenza A virus (FLUAV) particles was used as positive control. As assessed in a reporter assay (Fig. 1A and B), transfection of human 293T cells with RNAs isolated from ZEBOV and NiV particles (vRNA) resulted in strong activation of the IFN-beta promotor, in a manner similar to FLUAV vRNA (Fig. 1C). The constitutively active SV40 promoter, by contrast, was not activated by vRNAs, indicating specificity for the IFN system. Furthermore, RT-PCR analysis showed that treatment of cells with vRNAs resulted in a transcriptional upregulation of the IFN-beta gene as well as the IFN-stimulated genes IP-10, ISG56 and OAS1 (Fig. 1D), thus confirming our results with the reporter system. We concluded from these data that genomic RNAs of ZEBOV and NiV are potent elicitors of an IFN response.
###end p 12
###begin title 13
Genomic RNAs of ZEBOV and NiV activate the IFN response similar to FLUAV RNA.
###end title 13
###begin p 14
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 155 159 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Human 293T cells were transfected with luciferase reporter plasmids to measure activation of the inducible IFN-beta promoter and the constitutively active SV40 promoter, respectively. At 6 h post-transfection, cells were either mock treated or transfected with 1 microg viral genomic RNA (vRNA) of ZEBOV (A), NiV (B), or FLUAV (C). After overnight incubation, cells were lysed and promoter activities were normalised to the mock-induced samples. Mean values and standard deviations from 3 independent experiments are shown. (D) Detection of mRNAs for IFN-beta (panel 1) and the IFN-stimulated genes IP-10, ISG56, and OAS (panels 2 to 4). Detection of gamma-actin mRNA served as control (panel 5). 293T cells were transfected with 1 microg vRNA or 5 microg of the dsRNA analog poly(IC) and monitored 18 h later for gene upregulation by RT-PCR analysis.
###end p 14
###begin title 15
IFN induction depends on RIG-I and the 5' triphosphate group of genomic RNAs
###end title 15
###begin p 16
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Yoneyama1">[13]</xref>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g002">Fig. 2A</xref>
###xml 1002 1009 999 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g002">Fig. 2B</xref>
MDA5 and RIG-I are the main intracellular PRRs driving an antiviral innate immune response against RNA viruses [13]. To investigate which of these factors is required for the recognition of ZEBOV and NiV RNA, we established RNA interference (RNAi) in 293T cells, using short hairpin RNAs (shRNAs) expressed by retroviruses. Initially, for each target two different retroviral shRNA constructs were tested for their efficiency to knock down gene expression. In Fig. 2A it is demonstrated that the shRNA constructs MDA5 #1 and RIG-I #2 significantly and specifically reduced target expression levels, whereas MDA5 #2 and RIG-I #1 had more modest effects. Therefore, in all subsequent experiments, we used MDA5 #1 and RIG-I #2 for gene-specific knockdowns. As a next step, we pretreated cells with these constructs, incubated them for 5 days to establish RNAi, seeded them again and transfected them with viral RNAs. The IFN-beta promoter assay was used as a representative measure of cytokine induction. Fig. 2B shows that IFN induction by ZEBOV and NiV vRNAs was affected when RIG-I was downregulated. By contrast, MDA5 knockdown had no negative effect but sometimes increased IFN induction to some - statistically not significant - extent.
###end p 16
###begin title 17
IFN induction by NSV vRNAs depends on RIG-I and the 5' triphosphate group.
###end title 17
###begin p 18
###xml 540 547 537 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g001">Fig. 1A</xref>
###xml 937 944 931 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g001">Fig. 1A</xref>
###xml 32 37 <span type="species:ncbi:9606">Human</span>
(A) Verification of knockdowns. Human 293T cells were treated with retroviral shRNA constructs directed against either RIG-I or MDA5, and cotransfected with expression constructs for HA-tagged MDA5 (left panels) or GFP-fused RIG-I (right panels). Western blot analysis using antibodies against the respective fusion tags is shown. Detection of cellular beta-tubulin was used as an internal control. (B) Effect of shRNA knockdowns on IFN induction by viral RNAs, using the reporter constructs and RNA transfection protocols as described for Fig. 1A. The negative control shRNA construct (CTRL) targets the heat shock 70 interacting protein and was tested to have no effect on IFN induction (data not shown). (C) Genomic RNAs from ZEBOV and NiV were either mock treated, treated with SAP, or treated with SAP in the presence of the phosphatase inhibitor EDTA. IFN-beta reporter assays and RNA transfections were performed as described for Fig. 1A. Mean values and standard deviations from 3 independent experiments are shown.
###end p 18
###begin p 19
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Pichlmair2">[16]</xref>
###xml 382 389 382 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g002">Fig. 2C</xref>
RIG-I-dependent responses to FLUAV vRNA were previously shown to critically depend on the presence of a 5' triphosphate group [16]. In agreement with this, genomic RNAs from ZEBOV and NiV particles lost their IFN-inducing activities when treated with shrimp alkaline phosphatase (SAP). This effect could be inhibited by EDTA, excluding an unspecific effect of SAP on IFN induction (Fig. 2C).
###end p 19
###begin p 20
These data suggest that the 5'triphosphate group is the decisive molecular pattern triggering a RIG-I-dependent IFN response to genomic RNAs of ZEBOV and NiV.
###end p 20
###begin title 21
Genomic RNAs of segmented NSVs differ in their ability to trigger IFN induction
###end title 21
###begin p 22
###xml 156 168 156 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arenaviridae</italic>
###xml 204 216 204 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bunyaviridae</italic>
###xml 566 579 563 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g003">Fig. 3A and B</xref>
###xml 680 687 677 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g003">Fig. 3C</xref>
###xml 920 927 917 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g003">Fig. 3D</xref>
###xml 120 131 <span type="species:ncbi:11620">Lassa virus</span>
###xml 133 137 <span type="species:ncbi:11620">LASV</span>
###xml 232 255 <span type="species:ncbi:11588">Rift Valley fever virus</span>
###xml 257 261 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 283 296 <span type="species:ncbi:11599">Hantaan virus</span>
###xml 327 364 <span type="species:ncbi:11593">Crimean-Congo hemorrhagic fever virus</span>
###xml 366 371 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 404 408 <span type="species:ncbi:11620">LASV</span>
###xml 413 417 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 633 638 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
We extended our studies to NSV groups containing a segmented genome. As highly relevant representatives we investigated Lassa virus (LASV), a member of the Arenaviridae family, and several members of the Bunyaviridae family, namely Rift Valley fever virus (RVFV, genus phlebovirus), Hantaan virus (HTNV, genus hantavirus), and Crimean-Congo hemorrhagic fever virus (CCHFV, genus nairovirus). The RNAs of LASV and RVFV activated the IFN-beta promoter in a RIG-I- and 5' triphosphate-dependent manner as observed for the nonsegmented NSVs in the previous experiments (Fig. 3A and B). Surprisingly, however, RNAs isolated from HTNV and CCHFV particles did not trigger IFN induction (Fig. 3C). To rule out trivial explanations for the lack of stimulatory activity, we confirmed the identity and integrity of the bunyavirus genomic RNAs by RT-PCR analysis (see below) and denaturing formaldehyde agarose gel electrophoresis (Fig. 3D). Thus, in stark contrast to our findings with the other NSVs, the genomic RNAs of bunyaviruses belonging to the genera hantavirus and nairovirus are devoid of an IFN-inducing activity.
###end p 22
###begin title 23
Genomic RNAs of segmented NSVs.
###end title 23
###begin p 24
###xml 698 702 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Staunton1">[49]</xref>
###xml 38 42 <span type="species:ncbi:11620">LASV</span>
###xml 51 55 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 280 284 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 296 301 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 420 424 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 436 441 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
RNAs isolated from virus particles of LASV (A) and RVFV (B) were tested for their ability to activate the IFN-beta promoter in dependency of RIG-I or MDA5 (left panels) or 5' triphosphate groups (right panels). (C) IFN-beta promoter activation by genomic RNAs of the bunyaviruses RVFV, HTNV, and CCHFV. Mean values and standard deviations from 3 independent experiments are shown. (D) Purified virion RNAs (5 microg) of RVFV, HTNV, and CCHFV were separated on denaturing formaldehyde agarose gels. The genome segments (L, large; M, middle; S, small) are labeled on the right, and asterisks indicate 28S and 18S rRNA bands. Contamination of virus preparations with ribosomal RNAs are often observed [49] but have no consequences for IFN induction. As a control RNA isolated from ultracentrifuged supernatants of uninfected cells is shown (mock).
###end p 24
###begin title 25
Non-inducing viral RNAs contain a 5' monophosphate
###end title 25
###begin p 26
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Schlee1">[17]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Garcin1">[18]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Pak1">[19]</xref>
###xml 804 811 804 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g004">Fig. 4A</xref>
###xml 549 554 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 708 712 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 823 827 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 1017 1022 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
The absence of IFN induction by hantaviral and nairoviral RNA suggests a particular strategy to avoid RIG-I activation. As all initial products of RNA polymerases contain a triphosphorylated 5' end [17], we hypothesised that those viruses which possess non-inducing genomic RNAs have removed the 5' triphosphate group. In fact, for HTNV it was previously shown that the first nucleotide of the genome 5' end is cleaved off by a viral endonuclease activity ("prime and realign"), resulting in a monophosphorylated 5' end [18]. To investigate whether CCHFV may follow a similar strategy, we employed a 5'-3' exonuclease which specifically digests ssRNA having a 5' monophosphate [19]. As control, we incubated RVFV RNA which should be protected from enzymatic degradation due to its 5' triphosphate group. Fig. 4A shows that RVFV RNA can still be detected after treatment with the 5' monophosphate-specific RNase (panel 1), whereas HTNV RNA is degraded (panel 2). A similar RNase sensitivity was observed with RNA from CCHFV particles (panel 3). Thus, the inability of viral RNAs to activate RIG-I-dependent IFN induction correlates with the presence of a 5' monophosphate.
###end p 26
###begin title 27
Non-inducing viral RNAs contain a 5' monophosphate.
###end title 27
###begin p 28
###xml 393 394 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Garcin1">[18]</xref>
###xml 13 17 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 48 53 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 485 490 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 773 776 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 890 893 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
(A) vRNAs of RVFV (panel 1), HTNV (panel 2) and CCHFV (panel 3) were incubated with a 5'monophosphate-specific 5'-3' exonuclease. After 4 h of incubation, digestion efficacy was tested by RT-PCR analysis using primer pairs specific for the viral S segment. A comparison with untreated vRNAs is shown (lane input RNA). As additional controls, RNA was incubated without enzyme (lane buffer) or H2O was used for RT-PCR. The faint residual RT-PCR bands obtained after digestion of HTNV or CCHFV vRNAs are most likely caused by a minority of RNAs containing exonuclease-resistant 5'-OH ends. Such 5'-OH ends were previously observed for HTNV vRNA and thought to represent a preparation artifact [18]. (B) Activation of the IFN-beta promoter by genomic RNAs isolated from MV and BDV particles. Mean values and standard deviations from 3 independent experiments are shown. (C) Treatment of MV and BDV genomic RNAs with a 5' monophosphate-specific 5'-3' exonuclease and subsequent RT-PCR analysis.
###end p 28
###begin p 29
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Schneider1">[20]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Schneider2">[21]</xref>
###xml 285 292 285 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g004">Fig. 4B</xref>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g004">Fig. 4C</xref>
###xml 457 469 457 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bornaviridae</italic>
###xml 92 111 <span type="species:ncbi:12455">Borna disease virus</span>
###xml 113 116 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 163 166 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 233 246 <span type="species:ncbi:11234">measles virus</span>
###xml 248 250 <span type="species:ncbi:11234">MV</span>
###xml 305 308 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 322 324 <span type="species:ncbi:11234">MV</span>
###xml 421 424 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 534 539 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
An unusual mechanism of RNA replication was also proposed for one other member of the NSVs, Borna disease virus (BDV) [20], [21]. Interestingly, RNA isolated from BDV particles was unable to activate the IFN promoter, whereas RNA of measles virus (MV) was a good inducer, as expected (Fig. 4B). Moreover, BDV RNA, but not MV RNA, was undetectable after treatment with the 5' monophosphate-specific RNase (Fig. 4C). Thus, BDV, the sole representative of the Bornaviridae family, avoids RIG-I activation in a manner similar to HTNV and CCHFV, namely by generating a 5'-terminal monophosphate during the course of genome replication.
###end p 29
###begin title 30
Non-inducing viral RNAs are not bound by RIG-I
###end title 30
###begin p 31
###xml 207 228 207 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 419 425 419 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g005">Fig. 5</xref>
###xml 773 779 773 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002032-g005">Fig. 5</xref>
###xml 289 293 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 301 306 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 311 314 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 486 490 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 705 709 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 734 739 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 744 747 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
We wondered whether non-inducing vRNAs would differ from inducing vRNAs in the ability to bind RIG-I. To investigate this, we performed an RNA pulldown assay, using GFP-RIG-I coupled to Sepharose beads (see Materials and Methods). These GFP-RIG-I beads were incubated with vRNAs of either RVFV, HTNV, CCHFV, or BDV. After extensive washing, RNAs were isolated from the GFP-RIG-I beads and subjected to RT-PCR analysis. Fig. 5 (panel 1) shows that the 5' triphosphate-containing vRNA of RVFV was precipitated by the GFP-RIG-I beads, as expected. SAP treatment abrogated RIG-I binding (data not shown), thus confirming the dependency of the interaction on the 5'-terminal triphosphate group. In contrast to RVFV, particle RNAs of HTNV, CCHFV and BDV were not bound by RIG-I (Fig. 5, panels 2 to 4). These data support the notion that processing of RNA 5' ends enables viruses to escape RIG-I signaling and, hence, innate immune activation.
###end p 31
###begin title 32
vRNA binding by RIG-I.
###end title 32
###begin p 33
###xml 531 532 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 147 151 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 159 164 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 169 172 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 462 466 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 494 499 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 515 518 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
GFP-RIG-I expressed by 293T cells was coupled to protein G Sepharose beads via a GFP-specific antiserum. Beads were incubated with vRNAs of either RVFV, HTNV, CCHFV, or BDV. After extensive washing, RNAs were extracted from the precipitates and cDNA synthesis was performed using random hexanucleotide oligomers. An aliquot of 10% of the input RNA was kept as RT-PCR control (first lane). All precipitated RNAs were subjected to RT-PCR specific for sequences of RVFV (panel 1), HTNV (panel 2), CCHFV (panel 3), and BDV (panel 4). H2O was used as negative control.
###end p 33
###begin p 34
###xml 271 283 271 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bunyaviridae</italic>
###xml 288 300 288 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bornaviridae</italic>
Taken together, our results demonstrate that the genomic RNAs from several highly pathogenic NSVs trigger RIG-I-dependent cytokine induction via their 5'-terminal triphosphate group, whereas MDA5 plays no apparent role. In addition, we have uncovered that members of the Bunyaviridae and Bornaviridae have evolved a unique strategy to escape this potent pathogen sensing mechanism by removing the 5'-terminal triphosphate group from their genome.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 196 211 196 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paramyxoviridae</italic>
###xml 213 224 213 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Filoviridae</italic>
###xml 226 239 226 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rhabdoviridae</italic>
###xml 241 253 241 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bornaviridae</italic>
###xml 292 304 292 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arenaviridae</italic>
###xml 306 318 306 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bunyaviridae</italic>
###xml 320 336 320 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Orthomyxoviridae</italic>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Garcin1">[18]</xref>
###xml 827 840 827 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rhabdoviridae</italic>
###xml 860 876 860 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Orthomyxoviridae</italic>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Hornung1">[15]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Pichlmair2">[16]</xref>
###xml 1256 1259 1256 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Geisbert1">[9]</xref>
###xml 1261 1265 1261 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Kash1">[22]</xref>
###xml 1410 1414 1410 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Stoltz1">[23]</xref>
###xml 775 787 <span type="species:ncbi:11292">rabies virus</span>
###xml 792 818 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 979 984 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 989 992 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 1241 1245 <span type="species:ncbi:11620">LASV</span>
###xml 1251 1255 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 1325 1333 <span type="species:ncbi:9606">patients</span>
###xml 1446 1451 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 1455 1458 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
Viruses with a negative-stranded RNA genome are responsible for a wide range of diseases with significant medical and economical impact. They are divided into groups having a nonsegmented genome (Paramyxoviridae, Filoviridae, Rhabdoviridae, Bornaviridae) and those having a segmented genome (Arenaviridae, Bunyaviridae, Orthomyxoviridae). The genome replication strategy of NSVs involves primer-independent initiation of RNA synthesis by a single nucleotide. Due to this mechanism, all NSVs were believed to contain a triphosphate group at the 5' ends of their genomic RNAs, with the notable exception of hantaviruses for which a "prime and realign" mechanism was described [18]. However, to our knowledge, IFN-inducing 5' triphosphates have only been proven for the RNAs of rabies virus and vesicular stomatitis virus (family Rhabdoviridae) and FLUAV (family Orthomyxoviridae) [15], [16]. Here, we undertook a systematic study of all remaining NSV families and found that HTNV, CCHFV and BDV contain 5' monophosphates whereas all other NSVs tested indeed had triphosphates. These analyses suggest that the 5' triphosphate group may be a major determinant of the massive cytokine responses which are observed for infections with ZEBOV, NiV, LASV, and RVFV [9], [22]. By contrast, a recent study involving hantavirus-infected patients showed that type I IFN levels did not increase during the course of disease [23]. Moreover, IFN upregulation by CCHFV or BDV infection were not reported so far.
###end p 36
###begin p 37
###xml 189 192 189 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-GarciaSastre1">[4]</xref>
###xml 194 197 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Haller1">[5]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Garcin1">[18]</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Schneider1">[20]</xref>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Banerjee1">[24]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Elliott1">[25]</xref>
###xml 1001 1005 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Jin1">[26]</xref>
###xml 1580 1584 1580 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Schneider2">[21]</xref>
###xml 1586 1590 1586 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Meyer1">[27]</xref>
###xml 1675 1678 1675 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Ergonul1">[7]</xref>
###xml 240 245 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 250 253 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 582 585 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 671 676 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 842 847 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 1509 1512 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 1600 1605 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
In the recent years, an increasing number of viral proteins have been described which are effectively downregulating the induction of IFN and other cytokines, the so-called IFN antagonists [4], [5]. Our results using genomic RNA from HTNV, CCHFV and BDV establish the generation of 5'-terminal monophosphates as a novel strategy to avoid the activation of the IFN system. Interestingly, the mechanisms of 5' end processing differ between the viruses. HTNV employs prime-and realign to generate perfect complementary 5' and 3' genome ends able to form a panhandle structure, whereas BDV uses genome trimming resulting in a 3'end overhang [18], [20]. The strategy by which CCHFV processes its genome is currently unknown. However, viral RNA polymerases are only able to initiate RNA synthesis with a purine, but not with a pyrimidine [24], and CCHFV has 5'-terminal pyrimidine residues [25]. Moreover, for nairoviruses a previous study had suggested that polymerase slippage occurs during RNA synthesis [26]. These observations further support our claim that, for genome replication, nairoviruses utilize a similar prime and realign mechanism involving removal of the initiating 5' nucleotide as hantaviruses do. The fact that the largely unrelated bunyaviruses and bornaviruses apply apparently different means to reach the same goal strongly suggests an independent evolution towards genomic 5' monophosphates, driven by the selection pressure of RIG-I and the antiviral IFN system. Strikingly, both HTNV and BDV are known to establish persistent infection in their natural hosts [21], [27], and for CCHFV there is no evidence that it causes overt disease in carrier animals [7]. Possibly, the absence of a RIG-I ligand on the NSVs genome may facilitate the establishment of persistent or inapparent infection.
###end p 37
###begin p 38
###xml 251 254 251 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-GarciaSastre1">[4]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Billecocq1">[28]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Weber2">[34]</xref>
###xml 704 707 704 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-GarciaSastre1">[4]</xref>
###xml 709 713 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Blakqori1">[29]</xref>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-LeMay1">[35]</xref>
###xml 971 975 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Brzozka1">[30]</xref>
###xml 976 980 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Shaw1">[33]</xref>
###xml 1668 1672 1668 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Strahle1">[36]</xref>
###xml 630 647 <span type="species:ncbi:11320">influenza A virus</span>
All NSV groups which were found to possess 5' triphosphates, namely paramyxoviruses, rhabdoviruses, filoviruses, arenaviruses, orthobunya- and phleboviruses and orthomyxoviruses are known to encode IFN antagonists acting on the level of IFN induction [4], [28]-[34]. Moreover, the fact that ssRNA with a triphosphorylated 5' end is an excellent trigger of RIG-I implies that an increase in the number of genome segments contained within infecting particles requires an increasingly strong and early anti-IFN function as a counterbalance. Indeed, orthobunyaviruses and phleboviruses, which have a tripartite genome, as well as the influenza A virus which has eight segments express potent IFN antagonists [4], [29], [35]. Interestingly, these segmented NSVs dedicate particular non-structural proteins (NSs for Bunyaviruses, NS1 for influenza virus) to silence the IFN system, whereas two-segmented and nonsegmented NSVs mostly employ structural proteins for this purpose [30]-[33]. This observation may implicate that for NSVs with few genome segments and hence few RIG-I ligands it is sufficient to endow structural proteins with an additional IFN-antagonistic function, whereas a higher number of genome segments requires either strong and specialized factors like NS1 and NSs, or the removal of the RIG-I ligands. Moreover, the fact that NSVs containing 5' triphosphates elicit strong cytokine responses despite the presence of IFN-antagonistic proteins indicates that the balance between induction and viral inhibition is disturbed at some point during infection, possibly by a surplus of non-functional genomes such as produced by defective interfering particles [36] or by infection of cells which are resistant to the action of viral IFN antagonists.
###end p 38
###begin p 39
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Jskelinen1">[37]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Alff1">[38]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Spiropoulou1">[39]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Unterstab1">[40]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-LeGoffic1">[41]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-tenOever2">[45]</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Paladino1">[46]</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Prescott1">[47]</xref>
###xml 199 202 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 261 266 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
In addition to the removal of the RIG-I ligand, hantaviruses modulate IFN induction by a weakly active NSs protein [37] and by an additional function of their glycoproteins [38], [39]. Likewise, the BDV P protein interferes with IFN induction [40], whereas for CCHFV no IFN antagonistic protein has been identified so far. The necessity to actively abrogate IFN induction despite the absence of the 5'triphosphate group may be due to the presence of other viral structures which trigger an innate immune response, e.g. viral nucleocapsids or traces of dsRNA which were shown to play a role in NSV cytokine activation [41]-[45]. Moreover, enveloped virus particles by themselves can activate IRF-3 in a TLR- and RIG-I-independent manner [46], [47], implicating that mammalian hosts can respond to several independent hallmarks of virus infection.
###end p 39
###begin p 40
In summary, our study of the negative-stranded group of RNA viruses revealed that genome recognition by RIG-I is indeed a widespread phenomenon, but that hantaviruses, nairoviruses and bornaviruses avoid induction of antiviral responses by processing their RNA termini. These findings may help to better understand viral pathogenesis and particular cytokine profiles observed during infections.
###end p 40
###begin title 41
Materials and Methods
###end title 41
###begin title 42
Chemicals, cells and viruses
###end title 42
###begin p 43
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 484 490 <span type="species:ncbi:9913">bovine</span>
###xml 539 543 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 561 563 <span type="species:ncbi:11234">MV</span>
###xml 569 572 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 728 732 <span type="species:ncbi:11620">LASV</span>
###xml 752 757 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
Puromycin (Sigma) was dissolved in H2O to 2 microg/microl and used at a concentration of 2 microg/ml cell culture medium. Polyethylen glycol (PEG) 8000 and poly(IC) were dissolved and used as indicated by the manufacturer (Sigma). Simian VeroE6 cells and human 293T cells were cultivated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS. Stocks of FLUAV strain PR/8/34 were prepared under BSL-2 conditions by culturing MDCKII cells in DMEM supplemented with 10% bovine serum albumin, containing 1 microg/ml trypsine. RVFV strain Clone 13, MV, and BDV were propagated in Vero cells under BSL-2 conditions. HTNV strain 76-118 was propagated in VeroE6 cells under BSL-3 conditions. NiV, ZEBOV strain Mayinga, LASV strain Josiah, and CCHFV strain IbAr10200 were propagated in VeroE6 cells under BSL-4 conditions.
###end p 43
###begin title 44
Plasmid constructs
###end title 44
###begin p 45
###xml 159 163 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Yoneyama2">[48]</xref>
###xml 217 224 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 474 478 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002032-Pichlmair2">[16]</xref>
###xml 189 193 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 284 288 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
The firefly luciferase reporter construct for monitoring IFN-beta promoter activation (p125Luc) was kindly provided by Takashi Fujita, Kyoto University, Japan [48]. The control plasmid pRL-SV40 (Promega) contains the Renilla luciferase gene under control of the constitutively active SV40 promoter. Expression plasmids pHA-MDA5 encoding human MDA5 fused to an N-terminal HA tag and pGFP-RIG-I expressing human RIG-I fused to the C terminus of EGFP were described previously [16].
###end p 45
###begin title 46
Preparation of virus particles
###end title 46
###begin p 47
###xml 58 63 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 80 84 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 106 108 <span type="species:ncbi:11234">MV</span>
###xml 118 122 <span type="species:ncbi:11620">LASV</span>
###xml 151 154 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 435 439 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 441 443 <span type="species:ncbi:11234">MV</span>
###xml 445 448 <span type="species:ncbi:12455?0.8134328358208955">BDV</span>
###xml 509 514 <span type="species:ncbi:11593?0.6842105263157895">CCHFV</span>
###xml 567 571 <span type="species:ncbi:11620">LASV</span>
Supernatants from infected cells were harvested at day 2 (CCHFV), day 3 (FLUAV, RVFV, NiV), day 4 (ZEBOV, MV), day 7 (LASV), day 10 (HTNV), or day 60 (BDV) post-infection. For preparation of virus particles, cell culture supernatants were first pre-cleared from cell debris by centrifuging at 1500 rpm for 10 min and 4degreesC. Then, virus particles were concentrated either by ultracentrifugation at 24,000 rpm for 2 h and 4degreesC (RVFV, MV, BDV), ultracentrifugation at 45,000 rpm for 3.5 h at 4degreesC (CCHFV, HTNV), or by PEG precipitation (FLUAV, NiV, ZEBOV, LASV). IFN-inducing properties are not affected by the method of virus concentration (data not shown). For PEG-mediated particle precipitation, 175 ml of pre-cleared cell culture supernatant were supplied with 12.25 g PEG 8000 and 4.02 g NaCl and stirred overnight at 4degreesC. Then, samples were transferred into 50 ml Falcons and centrifuged at 6,000 rpm for 45-60 min at 4degreesC. The pellet was dissolved in 1.5 ml of TriFast reagent (Peqlab). RNA isolation was performed as described by the manufacturer.
###end p 47
###begin title 48
Transient transfections and reporter gene assays
###end title 48
###begin p 49
###xml 121 125 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Subconfluent 293T cell monolayers grown in 12-well dishes were transfected with 0.25 microg p125-Luc and 0.05 microg pRL-SV40 in 100 microl OptiMEM (Gibco-BRL) containing 0.9 microl Fugene HD (Roche). After 6 h at 37degreesC, the liposome-DNA mixture was removed and cells were transfected either with 1 microg of viral RNA or with 5 microg of poly(IC) using 3 microl Metafectene (Biontex) per microg RNA prepared in 100 microl OptiMEM. At 18 h post transfection, cells were harvested and lysed in 100 microl of Passive Lysis Buffer (Promega). An aliquot of 20 microl lysate was used to measure luciferase activities using the dual luciferase assay (Promega).
###end p 49
###begin title 50
RT-PCR analysis
###end title 50
###begin p 51
RNA was extracted using the TriFast reagent (Peqlab) and treated with DNase I. Reverse transcription was performed with 200 U of RevertAid H Minus M-MuLV (Fermentas) and 200 ng random hexanucleotides in 20 microl 1x M-MuLV RT reaction buffer supplied with 1 mM of each deoxynucleotide triphosphate (dNTP) and 40 U RNase Inhibitor (Fermentas). The resulting cDNA was amplified by 35 cycles of PCR, with each cycle consisting of 30 sec at 95degreesC, 30 sec at 55degreesC, and 90 sec at 68degreesC, followed by a final elongation step for 10 min at 68degreesC. Primer sequences are available upon request.
###end p 51
###begin title 52
shRNA knockdowns
###end title 52
###begin p 53
###xml 305 310 <span type="species:ncbi:9606">human</span>
Gene silencing by RNAi was achieved using shRNAs expressed by retroviruses (shRNAmir constructs, Open Biosystems). The construct which efficiently targets MDA5 had the catalog number RHS1764-9494563 (MDA5 #1) whereas RIG-I was targeted with RHS1764-9499511 (RIG-I #2). The control shRNA construct targets human Hsp 70 interacting protein and contained the sequence RHS1764-9500871. For establishing RNAi, 293T cells grown in 6-well dishes to 80% confluency were transfected with 1 microg each of pVpack-VSV G, pVpack-GP (Stratagene) and the shRNA construct, subcultured, incubated with Puromycin at day 3 post-transfection, and then incubated for another 2 to 3 days before usage.
###end p 53
###begin title 54
Enzymatic treatments of RNA
###end title 54
###begin p 55
To remove 5'-terminal phosphates, purified RNAs were treated with 1 U of shrimp alkaline phosphatase (SAP) according to the protocol of the manufacturer (Roche). After incubation at 37degreesC for 10 min in the presence or absence of the inhibitor 1 mM EDTA, the enzyme was heat-inactivated at 65degreesC for 15 min.
###end p 55
###begin p 56
###xml 408 409 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Terminatortrade mark (Epicentre Biotechnologies) is a 5'-3' exonuclease able to digest ssRNA with a 5' monophosphate. To determine the presence of a 5' monophosphate on genomic RNAs isolated from virus particles, 500 ng of RNA were either mock treated or incubated with 1 U of Terminator exonuclease for 4 h at 30degreesC. The RNA was then purified using RNAeasy Mini Kit (QIAGEN), eluated in nuclease-free H2O and treated with 1 U DNase (Fermentas). To check for the presence of RNA, RT-PCR analysis was performed as indicated above.
###end p 56
###begin title 57
RNA pulldown analysis
###end title 57
###begin p 58
###xml 957 958 919 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 463 469 <span type="species:ncbi:9986">rabbit</span>
Human 293T cells grown in 6-well dishes to 60% confluency were transfected with 1 microg pGFP-RIG-I per well. After 40 h of incubation, cells were washed with phosphate-buffered saline and lysed for 10 min at room temperature in 200 microl of RIPA buffer (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1% NP-40, complete protease inhibitor mix (Roche)). In parallel, 20 microl of a 50% slurry of protein G Sepharose in RIPA buffer were preadsorbed with 5 microl polyclonal rabbit anti-GFP antiserum (Invitrogen) and incubated for 2 h at 4degreesC. Then, the Sepharose beads were washed three times with RIPA buffer and incubated for 2 h at 4degreesC with the lysate equivalent of half a 6-well plate of transfected 293T cells. The immunoprecipitates were washed three times with RIPA buffer and then incubated with 1 microg of viral RNA for a further 2 h at 4degreesC. After three washing steps using RIPA buffer, the volume of the Sepharose beads was adjusted with H2O to 100 microl and RNA was extracted using the RNeasy kit (Qiagen). RNA pulldown was analysed by RT-PCR using random hexamers for RT and virus-specific primers for PCR.
###end p 58
###begin p 59
###xml 139 150 <span type="species:ncbi:11620">Lassa virus</span>
We thank Otto Haller for support and helpful comments, and Georg Kochs and Peter Staeheli for critically reading the manuscript. Nipah and Lassa virus stocks were provided by Sandra Diederich and Thomas Strecker, respectively (both University of Marburg).
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
RIG-I: tri-ing to discriminate between self and non-self RNA.
###end article-title 61
###begin article-title 62
Innate Recognition of Viruses.
###end article-title 62
###begin article-title 63
Toll-like receptor control of the adaptive immune responses.
###end article-title 63
###begin article-title 64
Type 1 interferons and the virus-host relationship: a lesson in detente.
###end article-title 64
###begin article-title 65
The interferon response circuit: induction and suppression by pathogenic viruses.
###end article-title 65
###begin article-title 66
Hendra and Nipah viruses: different and dangerous.
###end article-title 66
###begin article-title 67
Crimean-Congo haemorrhagic fever.
###end article-title 67
###begin article-title 68
###xml 0 11 <span type="species:ncbi:205488">Ebola virus</span>
Ebola virus: from discovery to vaccine.
###end article-title 68
###begin article-title 69
Exotic emerging viral diseases: progress and challenges.
###end article-title 69
###begin article-title 70
Triggering the innate antiviral response through IRF-3 activation.
###end article-title 70
###begin article-title 71
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.
###end article-title 71
###begin article-title 72
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.
###end article-title 72
###begin article-title 73
Function of RIG-I-like receptors in antiviral innate immunity.
###end article-title 73
###begin article-title 74
Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses.
###end article-title 74
###begin article-title 75
5'-Triphosphate RNA Is the Ligand for RIG-I.
###end article-title 75
###begin article-title 76
RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5' Phosphates.
###end article-title 76
###begin article-title 77
Beyond double-stranded RNA-type I IFN induction by 3pRNA and other viral nucleic acids.
###end article-title 77
###begin article-title 78
###xml 15 28 <span type="species:ncbi:11599">Hantaan virus</span>
The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis.
###end article-title 78
###begin article-title 79
###xml 71 81 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
Distinct populations of primary and secondary effectors during RNAi in C. elegans.
###end article-title 79
###begin article-title 80
###xml 71 90 <span type="species:ncbi:12455">Borna disease virus</span>
Genome trimming: a unique strategy for replication control employed by Borna disease virus.
###end article-title 80
###begin article-title 81
Genome trimming by Borna disease viruses: Viral replication control or escape from cellular surveillance?
###end article-title 81
###begin article-title 82
Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence.
###end article-title 82
###begin article-title 83
###xml 78 86 <span type="species:ncbi:9606">Patients</span>
Lambda Interferon (IFN-{lambda}) in Serum Is Decreased in Hantavirus-Infected Patients, and In Vitro-Established Infection Is Insensitive to Treatment with All IFNs and Inhibits IFN-{gamma}-Induced Nitric Oxide Production.
###end article-title 83
###begin article-title 84
5'-terminal cap structure in eucaryotic messenger ribonucleic acids.
###end article-title 84
###begin article-title 85
###xml 38 54 <span type="species:ncbi:11595">Dugbe nairovirus</span>
Non-viral sequences at the 5' ends of Dugbe nairovirus S mRNAs.
###end article-title 85
###begin article-title 86
Persistent hantavirus infections: characteristics and mechanisms.
###end article-title 86
###begin article-title 87
###xml 15 38 <span type="species:ncbi:11588">Rift Valley fever virus</span>
NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.
###end article-title 87
###begin article-title 88
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.
###end article-title 88
###begin article-title 89
###xml 22 34 <span type="species:ncbi:11292">rabies virus</span>
Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3.
###end article-title 89
###begin article-title 90
###xml 0 11 <span type="species:ncbi:205488">Ebola virus</span>
Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
###end article-title 90
###begin article-title 91
###xml 95 129 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.
###end article-title 91
###begin article-title 92
###xml 28 39 <span type="species:ncbi:121791">Nipah virus</span>
Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways.
###end article-title 92
###begin article-title 93
Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.
###end article-title 93
###begin article-title 94
TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus.
###end article-title 94
###begin article-title 95
###xml 0 12 <span type="species:ncbi:11191">Sendai virus</span>
Sendai virus defective-interfering genomes and the activation of interferon-beta.
###end article-title 95
###begin article-title 96
Tula and Puumala Hantavirus NSs ORFs are Functional and the Products Inhibit Activation of the Interferon-Beta Promoter.
###end article-title 96
###begin article-title 97
The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses.
###end article-title 97
###begin article-title 98
Andes and Prospect Hill Hantaviruses Differ in Early Induction of Interferon although Both Can Downregulate Interferon Signaling.
###end article-title 98
###begin article-title 99
Viral targeting of the interferon-beta inducing Traf family member-associated NF-kB activator-(TANK) binding kinase-1.
###end article-title 99
###begin article-title 100
###xml 61 78 <span type="species:ncbi:11320">influenza A virus</span>
Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.
###end article-title 100
###begin article-title 101
###xml 113 118 <span type="species:ncbi:9606">Human</span>
Cutting Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial Cells.
###end article-title 101
###begin article-title 102
###xml 104 131 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.
###end article-title 102
###begin article-title 103
###xml 19 32 <span type="species:ncbi:11234">measles virus</span>
Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation.
###end article-title 103
###begin article-title 104
###xml 46 72 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
Activation of TBK1 and IKK epsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
###end article-title 104
###begin article-title 105
The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I.
###end article-title 105
###begin article-title 106
Early innate immune responses to sin nombre hantavirus occur independently of IFN regulatory factor 3, characterized pattern recognition receptors, and viral entry.
###end article-title 106
###begin article-title 107
Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.
###end article-title 107
###begin article-title 108
Sequence analyses of Thogoto viral RNA segment 3: evidence for a distant relationship between an arbovirus and members of the Orthomyxoviridae.
###end article-title 108
###begin p 109
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 109
###begin p 110
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Work in the authors' laboratories is supported by the grants We 2616/5-1 (FW) and SFB 535 (MS, EM) from the Deutsche Forschungsgemeinschaft, by the grant K2007-56X-20349-01-3 from the Swedish Medicine Council (AM), and by the Swedish Society for Medical Research (JK).
###end p 110

